Experimental Research Compounds

Triple agonist studied for the most aggressive weight reduction signals in metabolic research.

Soluble activin receptor researched as a myostatin and activin trap to promote lean mass.

Experimental peptide studied for selective destruction of fat-tissue blood supply.

Glycoprotein researched for myostatin inhibition and muscle hypertrophy.

Designed senolytic peptide studied for clearing senescent cells in aging research.

Small molecule (not a peptide) researched as an ERR-α/β/γ agonist exercise mimetic.

Dual GLP-1/Glucagon agonist researched for weight and liver outcomes.

Full-length adrenocorticotropic hormone studied for adrenal stimulation and HPA axis research.

Russian-developed peptide analog studied for cognition, mood, and stress resilience.

Single-chain relaxin analog studied for anti-fibrotic and cardioprotective effects.

Neural cell adhesion molecule (NCAM) mimetic studied for synaptic plasticity.

Spadin-derived peptide researched as a TREK-1 channel blocker for depression models.

Research peptide that selectively disrupts cancer cell membranes in laboratory studies.

Cell-penetrating research peptide studied for Pin1 modulation and neuroprotection.

Khavinson short peptide researched for urinary bladder tissue support.